Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 103546, 10 pages
http://dx.doi.org/10.1155/2015/103546
Research Article

Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland

1School of Pharmaceutical Sciences, University of Geneva-University of Lausanne, 1205 Geneva, Switzerland
2Community Pharmacy, Department of Ambulatory Care & Community Medicine, University of Lausanne, 1011 Lausanne, Switzerland

Received 22 May 2015; Accepted 23 August 2015

Academic Editor: Alessandra Marengoni

Copyright © 2015 Mélanie Lelubre et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Adherence to Long-Term Therapies—Evidence for Action, 2003, http://www.who.int/chp/knowledge/publications/adherence_report/en/.
  2. B. Vrijens, S. De Geest, D. A. Hughes et al., “A new taxonomy for describing and defining adherence to medications,” British Journal of Clinical Pharmacology, vol. 73, no. 5, pp. 691–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Ortego, T. B. Huedo-Medina, J. Llorca et al., “Adherence to highly active antiretroviral therapy (HAART): a meta-analysis,” AIDS and Behavior, vol. 15, no. 7, pp. 1381–1396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Jeanneret, F. Lüthi, M. P. Schneider, S. Troxler, and O. Bugnon, “Adhésion thérapeutique aux traitements oncologiques oraux et prise en charge interdisciplinaire,” Revue Médicale Suisse, vol. 7, no. 296, pp. 1154–1160, 2011. View at Google Scholar
  5. R. Nieuwlaat, W. Wilczynski, T. Navarro et al., “Interventions for enhancing medication adherence,” The Cochrane Database of Systematic Reviews, vol. 11, Article ID CD000011, 2014. View at Publisher · View at Google Scholar
  6. IMS Institute for Healthcare Informatics, “Advancing the responsible use of medicines—applying levers for change—summary,” p. 1–24, 2012, http://www.imshealth.com/portal/site/imshealth/menuitem.762a961826aad98f53c753c71ad8c22a/?vgnextoid=faf9ee0a8e631410VgnVCM10000076192ca2RCRD&vgnextchannel=736de5fda6370410VgnVCM10000076192ca2RCRD&vgnextfmt=default.
  7. O. Bugnon and M. Buchmann, “Pharmacie d’officine et médecine interne générale à la croisée des mêmes chemins: des opportunités à saisir,” Revue Médicale Suisse, vol. 8, no. 364, pp. 2287–2291, 2012. View at Google Scholar
  8. M.-P. Schneider and P. Aslanio, “Adherence policy, education and practice—an international perspective,” Pharmacy Practice, vol. 8, no. 4, pp. 209–212, 2010. View at Google Scholar · View at Scopus
  9. D. Drotar, “Strategies of adherence promotion in the management of pediatric chronic conditions,” Journal of Developmental and Behavioral Pediatrics, vol. 34, no. 9, pp. 716–729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Association Pharmaceutique Belge (APB), “Entretien d’accompagnement de nouvelle médication—L'ENM: un train à ne pas manquer,” Annales Pharmaceutiques Belges, vol. 9, 2013. View at Google Scholar
  11. K. M. Wells, T. Thornley, M. J. Boyd, and H. F. Boardman, “Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation,” Research in Social and Administrative Pharmacy, vol. 10, no. 1, pp. 58–71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. NICE, “Guidelines CG76,” 2009, http://www.nice.org.uk/guidance/cg76/resources.
  13. J. Demonceau, T. Ruppar, P. Kristanto et al., “Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis,” Drugs, vol. 73, no. 6, pp. 545–562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. http://www.medamigo.com.
  15. https://www.sispha.com/.
  16. J. D. Fisher, W. A. Fisher, K. R. Amico, and J. J. Harman, “An information-motivation-behavioral skills model of adherence to antiretroviral therapy,” Health Psychology, vol. 25, no. 4, pp. 462–473, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-B. Daeppen, C. Fortini, N. Bertholet et al., “Training medical students to conduct motivational interviewing: a randomized controlled trial,” Patient Education and Counseling, vol. 87, no. 3, pp. 313–318, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Bugnon, D. Hugentobler-Hampaï, J. Berger, and M. P. Schneider, “New roles for community pharmacists in modern health care systems: a challenge for pharmacy education and research,” Chimia, vol. 66, no. 5, pp. 304–307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Burnier, M. P. Schneider, A. Chioléro, C. L. F. Stubi, and H. R. Brunner, “Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions,” Journal of Hypertension, vol. 19, no. 2, pp. 335–341, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Krummenacher, M. Cavassini, O. Bugnon, R. Spirig, and M. P. Schneider, “Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study,” Pharmacy World and Science, vol. 32, no. 6, pp. 776–786, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Krummenacher, M. Cavassini, O. Bugnon, and M. P. Schneider, “An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring,” AIDS Care, vol. 23, no. 5, pp. 550–561, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Krummenacher, M. Cavassini, O. Bugnon, and M. P. Schneider, “Characteristics of HIV patients referred to a medication adherence program in Switzerland,” International Journal of Clinical Pharmacy, vol. 34, no. 3, pp. 426–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Krummenacher, B. Spencer, S. Du Pasquier, O. Bugnon, M. Cavassini, and M. P. Schneider, “Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme,” International Journal of Clinical Pharmacy, vol. 36, no. 4, pp. 716–724, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Gertsch, O. Michel, I. Locatelli et al., “Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study,” AIDS Patient Care and STDs, vol. 27, no. 4, pp. 208–210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. WHPA, “World’s health professions call for new emphasis on working together,” 2013, http://www.whpa.org/WHPA_Statement_collaborative_practice.pdf.
  26. S. Michie, M. Richardson, M. Johnston et al., “The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions,” Annals of Behavioral Medicine, vol. 46, no. 1, pp. 81–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Guignard and O. Bugnon, “Pharmaceutical care in community pharmacies: practice and research in Switzerland,” The Annals of Pharmacotherapy, vol. 40, no. 3, pp. 512–517, 2006. View at Publisher · View at Google Scholar · View at Scopus